| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia;
School of Molecular Bioscience, Washington State University, Pullman, WA 99164; and
School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, New South Wales, Australia
Controlled production of the cytokine IL-2 plays a key role in the mammalian immune system. Expression from the gene is tightly regulated with no detectable expression in resting T cells and a strong induction following T cell activation. The IL-2 proximal promoter (+1 to -300) contains many well-defined transcriptional activation elements that respond to T cell stimulation. To determine the role of chromatin structure in the regulation of interleukin-2 gene transcription, nucleosome assembly across the IL-2 promoter region was examined using in vitro chromatin reconstitution assays. The IL-2 promoter assembles a nucleosome that is both translationally and rotationally positioned, spanning some of the major functional control elements. The binding of transcription factors to these elements, with the exception of the architectural protein HMGA1, was occluded by the presence of the nucleosome. Analysis of the chromatin architecture of the IL-2 gene in Jurkat T cells provided evidence for the presence of a similarly positioned nucleosome in vivo. The region encompassed by this nucleosome becomes remodeled following activation of Jurkat T cells. These observations suggest that the presence of a positioned nucleosome across the IL-2 proximal promoter may play an important role in maintaining an inactive gene in resting T cells and that remodeling of this nucleosome is important for gene activation.
This article has been cited by other articles:
|
|
 |
|
  O. Desy, D. Carignan, M. Caruso, and P. O. de Campos-Lima Immunosuppressive Effect of Isopropanol: Down-Regulation of Cytokine Production Results from the Alteration of Discrete Transcriptional Pathways in Activated Lymphocytes J. Immunol., August 15, 2008; 181(4): 2348 - 2355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. McKarns and R. H. Schwartz Biphasic Regulation of Il2 Transcription in CD4+ T Cells: Roles for TNF-{alpha} Receptor Signaling and Chromatin Structure J. Immunol., July 15, 2008; 181(2): 1272 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Brettingham-Moore, O. R. Sprod, X. Chen, P. Oakford, M. F. Shannon, and A. F. Holloway Determinants of a transcriptionally competent environment at the GM-CSF promoter Nucleic Acids Res., May 1, 2008; 36(8): 2639 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Thomas, N. Chunder, C. Chen, S. E. Umetsu, S. Winandy, and A. D. Wells Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes J. Immunol., December 1, 2007; 179(11): 7305 - 7315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bostik, E. S. Noble, S. T. Stephenson, F. Villinger, and A. A. Ansari CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation J. Immunol., June 15, 2007; 178(12): 7720 - 7729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Webster, Y. Rodriguez, W. T. Klimecki, and D. Vercelli The Human IL-13 Locus in Neonatal CD4+ T Cells Is Refractory to the Acquisition of a Repressive Chromatin Architecture J. Biol. Chem., January 5, 2007; 282(1): 700 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Castellano, B. Vire, M. Pion, V. Quivy, D. Olive, I. Hirsch, C. Van Lint, and Y. Collette Active Transcription of the Human FASL/CD95L/TNFSF6 Promoter Region in T Lymphocytes Involves Chromatin Remodeling: ROLE OF DNA METHYLATION AND PROTEIN ACETYLATION SUGGEST DISTINCT MECHANISMS OF TRANSCRIPTIONAL REPRESSION J. Biol. Chem., May 26, 2006; 281(21): 14719 - 14728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Hwang, J.-H. Hong, and L. H. Glimcher IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508 J. Exp. Med., November 7, 2005; 202(9): 1289 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adachi and E. V. Rothenberg Cell-type-specific epigenetic marking of the IL2 gene at a distal cis-regulatory region in competent, nontranscribing T-cells Nucleic Acids Res., June 3, 2005; 33(10): 3200 - 3210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen, J. Wang, D. Woltring, S. Gerondakis, and M. F. Shannon Histone Dynamics on the Interleukin-2 Gene in Response to T-Cell Activation Mol. Cell. Biol., April 15, 2005; 25(8): 3209 - 3219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Thomas, L. Gao, and A. D. Wells Signals from CD28 Induce Stable Epigenetic Modification of the IL-2 Promoter J. Immunol., April 15, 2005; 174(8): 4639 - 4646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. McKarns, R. H. Schwartz, and N. E. Kaminski Smad3 Is Essential for TGF-{beta}1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation J. Immunol., April 1, 2004; 172(7): 4275 - 4284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Smith, I. Collins, G. V. R. Chandramouli, W. G. Butscher, E. Zaitseva, W. J. Freebern, C. M. Haggerty, V. Doseeva, and K. Gardner Targeting Combinatorial Transcriptional Complex Assembly at Specific Modules within the Interleukin-2 Promoter by the Immunosuppressant SB203580 J. Biol. Chem., October 17, 2003; 278(42): 41034 - 41046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rao, S. Gerondakis, D. Woltring, and M. F. Shannon c-Rel Is Required for Chromatin Remodeling Across the IL-2 Gene Promoter J. Immunol., April 1, 2003; 170(7): 3724 - 3731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Holloway, S. Rao, X. Chen, and M. F. Shannon Changes in Chromatin Accessibility Across the GM-CSF Promoter upon T Cell Activation Are Dependent on Nuclear Factor {kappa}B Proteins J. Exp. Med., February 17, 2003; 197(4): 413 - 423. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
